112 related articles for article (PubMed ID: 3550065)
1. Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapy.
Elkind-Hirsch KE; Platia MP; Schiff I
J Reprod Med; 1987 Jan; 32(1):5-9. PubMed ID: 3550065
[TBL] [Abstract][Full Text] [Related]
2. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
3. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine in hyperprolactinemic amenorrhea: a possible early effect on ovarian steroidogenesis.
Le Roith D; Potashnik G; Glick SM
Int J Fertil; 1979; 24(2):145-7. PubMed ID: 40911
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
6. alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.
Klibanski A; Beitins IZ; Zervas NT; McArthur JW; Ridgway EC
J Clin Endocrinol Metab; 1983 Apr; 56(4):774-80. PubMed ID: 6187760
[TBL] [Abstract][Full Text] [Related]
7. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
8. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy with bromocriptine and clomiphene citrate for patients with normoprolactinemic amenorrhea.
Kubota T; Kamada S; Aso T
Int J Fertil; 1992; 37(5):277-82. PubMed ID: 1358838
[TBL] [Abstract][Full Text] [Related]
10. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
Fukunaga T
Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic mechanisms and luteinizing hormone secretion. I. Acute administration of the dopamine agonist bromocriptine does not inhibit luteinizing hormone release in hyperprolactinemic women.
Evans WS; Rogol AD; MacLeod RM; Thorner MO
J Clin Endocrinol Metab; 1980 Jan; 50(1):103-7. PubMed ID: 7188612
[TBL] [Abstract][Full Text] [Related]
12. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
[TBL] [Abstract][Full Text] [Related]
13. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
Rjosk HK; Werder K; Fahlbusch R
Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
Sarkar DK; Yen SS
Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome.
Falaschi P; Rocco A; del Pozo E
J Clin Endocrinol Metab; 1986 Feb; 62(2):348-51. PubMed ID: 3510225
[TBL] [Abstract][Full Text] [Related]
16. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
17. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women.
Matera C; Freda PU; Ferin M; Wardlaw SL
J Clin Endocrinol Metab; 1995 Feb; 80(2):540-5. PubMed ID: 7852517
[TBL] [Abstract][Full Text] [Related]
19. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
20. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
